Stock Details
LH is Laboratory Corporation of America Holdings's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 261.17$. Average daily volumn in 3 months 844.8k. Market cap 23.04B



Stock symbol : LH. Exchange : NYSE. Currency : USD
Lastest price : 248.55$. Total volume : 814.97k. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Laboratory Corporation of America Holdings (LH)
Last Price
248.55$
Change
2.12
Volume
814.97k

Previous Close246.43
Open247.87
Day Range242.83-250.00
Bid214.00 x 800
Ask299.99 x 900
Volume814.97k
Average Volume844.8k
Market Cap23.04B
Beta1.04
52 Week Range232.01-317.17
Trailing P/E11.41
Foward P/E13.55
Dividend (Yield %)1.17%
Ex-Dividend Date2022-05-18



Financial Details


According to Laboratory Corporation of America Holdings's financial reports the company's revenue in 2021 were 16.12B an increase( +23.08%) over the years 2020 revenue that were of 13.98B. In 2021 the company's total earnings were 2.38B while total earnings in 2020 were 1.56B( +100%).


Loading ...



Organization

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other... substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations. It offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Market Cap:
23.04B
Revenue:
16.12B
Total Assets:
20.39B
Total Cash:
1.47B


News about "Laboratory Corporation of America Holdings"

investors-in-laboratory-corporation-of-america-holdings-nyselh-have-made-a-notable-return-of-76-over-the-past-five-years-image

Investors in Laboratory Corporation of America Holdings (NYSE:LH) have made a notable return of 76% over the past five years

Source from : YAHOO!Finance - 6 days ago

While Laboratory Corporation of America Holdings (NYSE:LH) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 10% in the last ...See details»


brokerages-set-laboratory-co-of-america-holdings-nyselh-price-target-at-30288-image

Brokerages Set Laboratory Co. of America Holdings (NYSE:LH) Price Target at $302.88

Source from : Defense World - 8 days ago

Shares of Laboratory Co. of America Holdings (NYSE:LH – Get Rating) have been given an average rating of “Buy” by the eleven research firms that are currently covering the firm, Marketbeat.com reports ...See details»


laboratory-co-of-america-holdings-nyselh-given-consensus-recommendation-of-buy-by-brokerages-image

Laboratory Co. of America Holdings (NYSE:LH) Given Consensus Recommendation of “Buy” by Brokerages

Source from : Defense World - 8 days ago

Shares of Laboratory Co. of America Holdings (NYSE:LH – Get Rating) have been given an average rating of “Buy” by the eleven research firms that are currently covering the firm, Marketbeat.com reports ...See details»


Laboratory Co. of America Holdings (LH) to Issue Quarterly Dividend of $0.72 on June 9th

Source from : ETF Daily News - 6 days ago

About Laboratory Co. of America (Get Rating) Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp ...See details»


Laboratory Corp. of America Holdings

Source from : Reuters - 1 year ago

As of on the New York Stock Exchange ∙ Minimum 15 minute delay Laboratory Corp of America Holdings raised its full-year profit forecast on Thursday, following strong demand at its unit that ...See details»


Laboratory Corporation of America Holdings 2022 Q1 - Results - Earnings Call Presentation

Source from : Seeking Alpha - 23 days ago

Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site ...See details»


Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q1 2022 Results - Earnings Call Transcript

Source from : Seeking Alpha - 24 days ago

And we became the first US commercial laboratory to offer quantitative tests for detecting and measuring unintentional gluten consumption, which can help with the management of celiac disease.See details»


Laboratory Corp of America Holdings - Stock Operating Performance LAB

Source from : Morningstar%2c Inc. - 7 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...See details»


Laboratory Corporation Of America Holdings Q1 Profit Decreases, but beats estimates

Source from : Nasdaq - 24 days ago

(RTTNews) - Laboratory Corporation Of America Holdings (LH) reported a profit for first quarter that decreased from last year but beat the Street estimates. The company's bottom line totaled $491 ...See details»


Laboratory Corporation of America Holdings (L1CA34)

Source from : Investing.com - 19 days ago

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»


Laboratory Corporation of America(LH)

Source from : The Motley Fool - 16 days ago

An independent clinical laboratory company that offers a range of clinical laboratory tests which are used by the medical profession in routine testing, patient diagnosis, and in the monitoring ...See details»


Returns on Capital Paint A Bright Future For Laboratory Corporation of America Holdings (NYSE:LH)

Source from : Yahoo Finance - 1 month ago

So when we looked at the ROCE trend of Laboratory Corporation of America Holdings (NYSE:LH) we really liked what we saw. For those who don't know, ROCE is a measure of a company's yearly pre-tax ...See details»


Laboratory Co. of America Holdings (NYSE:LH) Receives $302.88 Average Target Price from Analysts

Source from : ETF Daily News - 8 days ago

Laboratory Co. of America Company Profile (Get Rating) Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments ...See details»


Laboratory Corp. of America Holdings

Source from : MarketWatch - 25 days ago

Presently, Stephen M. Anderson is Chief Scientific Officer-Covance & Senior VP at Laboratory Corp. of America Holdings. Mr. Anderson is also on the board of OmniSeq, Inc. and Member of American ...See details»